Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Alx Oncology Holdings Inc (NASDAQ: ALXO) closed at $2.07 down -4.61% from its previous closing price of $2.17. In other words, the price has decreased by -$4.61 from its previous closing price. On the day, 0.89 million shares were traded. ALXO stock price reached its highest trading level at $2.215 during the session, while it also had its lowest trading level at $2.06.
Ratios:
For a deeper understanding of Alx Oncology Holdings Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.39 and its Current Ratio is at 4.39. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Stifel on March 08, 2024, Downgraded its rating to Hold and sets its target price to $14 from $10 previously.
On December 08, 2023, Jefferies Upgraded its rating to Buy which previously was Hold and also upped its target price recommendation from $8 to $18.
Jefferies Downgraded its Buy to Hold on December 22, 2021, whereas the target price for the stock was revised from $65 to $25.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Aug 14 ’24 when Pinto Shelly sold 564 shares for $2.58 per share. The transaction valued at 1,455 led to the insider holds 91,549 shares of the business.
Randolph Sophia sold 1,365 shares of ALXO for $3,522 on Aug 14 ’24. The CHIEF MEDICAL OFFICER now owns 325,711 shares after completing the transaction at $2.58 per share. On Aug 14 ’24, another insider, Pons Jaume, who serves as the PRESIDENT & CSO of the company, sold 1,937 shares for $2.58 each. As a result, the insider received 4,997 and left with 591,510 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALXO now has a Market Capitalization of 109030624 and an Enterprise Value of -30220394.
Stock Price History:
Over the past 52 weeks, ALXO has reached a high of $17.83, while it has fallen to a 52-week low of $1.88. The 50-Day Moving Average of the stock is -43.42%, while the 200-Day Moving Average is calculated to be -80.26%.
Shares Statistics:
For the past three months, ALXO has traded an average of 1.27M shares per day and 458790 over the past ten days. A total of 49.95M shares are outstanding, with a floating share count of 30.21M. Insiders hold about 42.64% of the company’s shares, while institutions hold 71.65% stake in the company. Shares short for ALXO as of 1724976000 were 9978290 with a Short Ratio of 7.87, compared to 1722384000 on 9083522. Therefore, it implies a Short% of Shares Outstanding of 9978290 and a Short% of Float of 32.860002.
